Figure 2.
ProteoVue Maps of the two pools of untreated amniotic fluid in the second set of experiments. (a) Group 1: patients with preterm labor without infection/inflammation who delivered at term (b)Group 3: patients who delivered preterm with intra-amniotic infection/inflammation. The region indicated by the box in (a) contains the fractions from which IGFBP-1 was subsequently identified.